User contributions for Justine Cadet
Jump to navigation
Jump to search
18 July 2012
- 18:3318:33, 18 July 2012 diff hist −6 Pulmonary embolism classification →Acute Pulmonary Embolism
26 June 2012
- 17:5217:52, 26 June 2012 diff hist −1 Deep vein thrombosis landmark trials in prevention →MAGELLANhttp://www.clinicaltrials.gov/ct2/show/NCT00571649?term=MAGELLAN&rank=1
- 17:3617:36, 26 June 2012 diff hist +5 Deep vein thrombosis landmark trials in prevention →MAGELLANhttp://www.clinicaltrials.gov/ct2/show/NCT00571649?term=MAGELLAN&rank=1
- 17:3417:34, 26 June 2012 diff hist −13 Deep vein thrombosis landmark trials in prevention →MAGELLANhttp://www.clinicaltrials.gov/ct2/show/NCT00571649?term=MAGELLAN&rank=1
- 17:3117:31, 26 June 2012 diff hist +6 Deep vein thrombosis landmark trials in prevention →MAGELLANhttp://www.clinicaltrials.gov/ct2/show/NCT00571649?term=MAGELLAN&rank=1
- 17:3017:30, 26 June 2012 diff hist 0 Deep vein thrombosis landmark trials in prevention →MAGELLANhttp://www.clinicaltrials.gov/ct2/show/NCT00571649?term=MAGELLAN&rank=1
- 17:2917:29, 26 June 2012 diff hist +82 Deep vein thrombosis landmark trials in prevention →MAGELLAN
- 17:2817:28, 26 June 2012 diff hist −1 Deep vein thrombosis landmark trials in prevention /* ADOPT{{cite journal |author=Goldhaber SZ, Leizorovicz A, Kakkar AK, et al. |title=Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients |journal=N. Engl. J. Med. |volume=365 |issue=23 |pages=2167–77 |year=2011 |month=Dec...
- 17:2717:27, 26 June 2012 diff hist +583 Deep vein thrombosis landmark trials in prevention →MAGELLAN
- 14:5214:52, 26 June 2012 diff hist +2,547 Deep vein thrombosis landmark trials in prevention →ADOPT
21 June 2012
- 00:5300:53, 21 June 2012 diff hist −1 Deep vein thrombosis landmark trials in treatment /* RECORD 3 Study{{cite journal |author=Kakkar AK, Brenner B, Dahl OE, et al. |title=Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised c...
- 00:5200:52, 21 June 2012 diff hist −61 Deep vein thrombosis landmark trials in treatment /* RECORD 3{{cite journal |author=Kakkar AK, Brenner B, Dahl OE, et al. |title=Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised control...
- 00:5100:51, 21 June 2012 diff hist +2,500 Deep vein thrombosis landmark trials in treatment /* RECORD 2 Study{{cite journal |author=Lassen MR, Ageno W, Borris LC, et al. |title=Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty |journal=N. Engl. J. Med. |volume=358 |issue=26 |pages=2776–86 |year=2008 |mo...
- 00:4500:45, 21 June 2012 diff hist +2,151 Deep vein thrombosis landmark trials in treatment /* RECORD 1 Study{{cite journal |author=Eriksson BI, Borris LC, Friedman RJ, et al. |title=Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty |journal=N. Engl. J. Med. |volume=358 |issue=26 |pages=2765–75 |year=2008 |mon...
- 00:3700:37, 21 June 2012 diff hist +3 Deep vein thrombosis landmark trials in treatment /* RECORD 1 Study{{cite journal |author=Eriksson BI, Borris LC, Friedman RJ, et al. |title=Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty |journal=N. Engl. J. Med. |volume=358 |issue=26 |pages=2765–75 |year=2008 |mon...
- 00:3400:34, 21 June 2012 diff hist −1 Deep vein thrombosis landmark trials in treatment /* =RECORD 1 Study{{cite journal |author=Eriksson BI, Borris LC, Friedman RJ, et al. |title=Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty |journal=N. Engl. J. Med. |volume=358 |issue=26 |pages=2765–75 |year=2008 |mo...
- 00:3300:33, 21 June 2012 diff hist +1 Deep vein thrombosis landmark trials in treatment /* =RECORD 1 Study{{cite journal |author=Eriksson BI, Borris LC, Friedman RJ, et al. |title=Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty |journal=N. Engl. J. Med. |volume=358 |issue=26 |pages=2765–75 |year=2008 |mo...
- 00:3200:32, 21 June 2012 diff hist +11 Deep vein thrombosis landmark trials in treatment /* =RECORD 1 Study{{cite journal |author=Eriksson BI, Borris LC, Friedman RJ, et al. |title=Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty |journal=N. Engl. J. Med. |volume=358 |issue=26 |pages=2765–75 |year=2008 |mo...
- 00:3000:30, 21 June 2012 diff hist +2,377 Deep vein thrombosis landmark trials in treatment /* EINSTEIN Study{{cite journal |author=Bauersachs R, Berkowitz SD, Brenner B, et al. |title=Oral rivaroxaban for symptomatic venous thromboembolism |journal=N. Engl. J. Med. |volume=363 |issue=26 |pages=2499–510 |year=2010 |month=December |pmid...
20 June 2012
- 12:0412:04, 20 June 2012 diff hist 0 Deep vein thrombosis future or investigational therapies →Acute Medically Ill venous thromboembolism (VTE) Prevention With Extended Duration Betrixaban Study (The APEX Study): Sponsored by Portola Pharmaceuticalshttp://clinicaltrials.gov/ct2/show/NCT01583218?term=APEX&rank=2
- 02:5502:55, 20 June 2012 diff hist +27 Deep vein thrombosis future or investigational therapies →Phase 3 Trials
- 02:5502:55, 20 June 2012 diff hist +31 Deep vein thrombosis future or investigational therapies →Acute Medically Ill venous thromboembolism (VTE) Prevention With Extended Duration Betrixaban Study (The APEX Study): Sponsored by Portola Pharmaceuticalshttp://clinicaltrials.gov/ct2/show/NCT01583218?term=APEX&rank=2
- 02:5402:54, 20 June 2012 diff hist −1 Deep vein thrombosis future or investigational therapies →Prolonged Anticoagulation After a First Episod of Idiopathic Proximal Deep Vein Thrombosis (PADIS TVP): Sponsored by University Hospital, Bresthttp://clinicaltrials.gov/ct2/show/NCT00740493?term=deep+vein+thrombosis&rank=16
- 02:5302:53, 20 June 2012 diff hist +845 Deep vein thrombosis future or investigational therapies →Prolonged Anticoagulation After a First Episod of Idiopathic Proximal Deep Vein Thrombosis (PADIS TVP): Sponsored by University Hospital, Bresthttp://clinicaltrials.gov/ct2/show/NCT00740493?term=deep+vein+thrombosis&rank=16
- 02:4502:45, 20 June 2012 diff hist +890 Deep vein thrombosis future or investigational therapies →Efficacy and Safety Study of Apixaban for Extended Treatment of DVT or PE: Sponsored by Bristol-Myers Squibb and Pfizer http://clinicaltrials.gov/ct2/show/NCT00633893
- 02:3102:31, 20 June 2012 diff hist +85 Deep vein thrombosis future or investigational therapies →Acute Medically Ill venous thromboembolism (VTE) Prevention With Extended Duration Betrixaban Study (The APEX Study): Sponsored by Portola Pharmaceuticalshttp://clinicaltrials.gov/ct2/show/NCT01583218?term=APEX&rank=2
- 02:2602:26, 20 June 2012 diff hist +9 Deep vein thrombosis future or investigational therapies →Acute Medically Ill venous thromboembolism (VTE) Prevention With Extended Duration Betrixaban Study (The APEX Study): Sponsored by Portola Pharmaceuticalshttp://clinicaltrials.gov/ct2/show/NCT01583218?term=APEX&rank=2
- 02:2502:25, 20 June 2012 diff hist +16 Deep vein thrombosis future or investigational therapies →Phase 3 Trials
- 02:2402:24, 20 June 2012 diff hist +74 Deep vein thrombosis future or investigational therapies →Phase 3 Trials
- 02:2302:23, 20 June 2012 diff hist +11 Deep vein thrombosis future or investigational therapies →Phase 3 Trials
- 02:2102:21, 20 June 2012 diff hist 0 Deep vein thrombosis future or investigational therapies →Ongoing Research
- 02:0902:09, 20 June 2012 diff hist −20 Deep vein thrombosis future or investigational therapies →Ongoing Research
- 02:0702:07, 20 June 2012 diff hist +675 Deep vein thrombosis future or investigational therapies →Ongoing Research
- 01:4301:43, 20 June 2012 diff hist +22 m Deep vein thrombosis future or investigational therapies →Ongoing Research
- 01:3801:38, 20 June 2012 diff hist +425 Deep vein thrombosis future or investigational therapies →Ongoing Research
- 01:3301:33, 20 June 2012 diff hist +1 Deep vein thrombosis future or investigational therapies →Ongoing Research
- 01:3201:32, 20 June 2012 diff hist 0 Deep vein thrombosis future or investigational therapies →Ongoing Research
- 01:3001:30, 20 June 2012 diff hist +61 Deep vein thrombosis future or investigational therapies →Ongoing Research
- 01:2901:29, 20 June 2012 diff hist +420 N Deep vein thrombosis future or investigational therapies Created page with "==Ongoing Research== '''Phase 3 Trials''' Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism: Sponsored by Bristol-Mye..."
- 01:0901:09, 20 June 2012 diff hist −7 Deep vein thrombosis history and symptoms →Less Common Symptoms
- 01:0801:08, 20 June 2012 diff hist −1 Deep vein thrombosis laboratory tests →Use in DVT diagnosis
- 01:0601:06, 20 June 2012 diff hist +562 Deep vein thrombosis cost-effectiveness of therapy →Overview
19 June 2012
18 June 2012
- 22:4222:42, 18 June 2012 diff hist −35 Deep vein thrombosis screening →Screening methods
- 22:4022:40, 18 June 2012 diff hist +530 Deep vein thrombosis screening →Screening methods
16 June 2012
- 18:1818:18, 16 June 2012 diff hist 0 Deep vein thrombosis risk factors →Modifiable risk factors
- 18:1818:18, 16 June 2012 diff hist +321 Deep vein thrombosis risk factors →Temporary risk factors
- 18:1418:14, 16 June 2012 diff hist +1 Deep vein thrombosis risk factors →Modifiable risk factors
- 18:1318:13, 16 June 2012 diff hist −4 Deep vein thrombosis risk factors →Modifiable risk factors
- 18:1118:11, 16 June 2012 diff hist +1 Deep vein thrombosis risk factors →Modifiable risk factors